Sarah Stewart (cancer researcher) at the age of 39. Stewart returned to the NIH in 1951, joining the National Cancer Institute (NCI), and eventually becoming medical director. Stewart developed an interest in researching viral links to cancer in light of the pioneering research of Jonas Salk in developing a vaccine for the virus which caused polio. Stewart developed an interest in researching viral links to cancer in light of the pioneering research of Jonas Salk in developing a vaccine for the virus which caused polio. Stewart is credited with discovering the Polyomavirus in 1953. She and research partner, Dr. Bernice E. Eddy, were successful
Remune P < 0.05 & HIV-1 lymphocyte proliferation P < 0.001 both favoring the Remune Group. The International AIDS Vaccine Research (IAVA) issued a report on “Whole Killed AIDS Vaccines” in 1999 reviewing a diverse aspect of the killed virus approach. Remune Remune is the first therapeutic HIV vaccine based on the killed whole virus approach. Remune was initially invented by Jonas Salk in 1987 and is now being developed by Immune Response BioPharma, Inc. (IRBP) Remune is a therapeutic HIV/AIDS vaccine that has completed over 25 clinical studies to date and shows a robust mechanism of action restoring white blood